These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 76573)

  • 1. Lack of phosphorylatable site and some kinetic properties of erythrocyte pyruvate kinase from the rat. A modified L-type isozyme?
    Dahlqvist-Edberg U
    FEBS Lett; 1978 Apr; 88(1):139-43. PubMed ID: 76573
    [No Abstract]   [Full Text] [Related]  

  • 2. The immunological properties of pyruvate kinase. II. The relationship of the human erythrocyte isozyme to the human liver isozymes.
    Lincoln DR; Black JA; Rittenberg MB
    Biochim Biophys Acta; 1975 Dec; 410(2):279-84. PubMed ID: 54192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteolytic processing of human L-type pyruvate kinase increases its ability to be phosphorylated.
    Marie J; Kahn A
    Biochem Biophys Res Commun; 1980 Jun; 94(4):1387-93. PubMed ID: 7396967
    [No Abstract]   [Full Text] [Related]  

  • 4. An isozyme of erythrocyte pyruvate kinase (PK-Los Angeles) with impaired kinetics corrected by fructose-1, 6-diphosphate.
    Paglia DE; Valentine WN; Williams KO; Konrad PN
    Am J Clin Pathol; 1977 Aug; 68(2):229-34. PubMed ID: 18004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythrocyte pyruvate kinase deficiency associated with kinetically aberrant isozyme.
    Yamada K; Adachibara A; Nakazawa S; Shinkai A; Nishina T
    Nihon Ketsueki Gakkai Zasshi; 1974 Feb; 37(1):17-24. PubMed ID: 4858634
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparative kinetic behaviour and regulation by fructose-1,6-bisphosphate and ATP of pyruvate kinase from erythrocytes, reticulocytes and bone marrow cells.
    Rodriguez-Horche P; Luque J; Perez-Artes E; Pineda M; Pinilla M
    Comp Biochem Physiol B; 1987; 87(3):553-7. PubMed ID: 3621913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mathematical model of pyruvate kinase of chicken erythrocytes.
    Jacobasch G; Holzhütter HG; Gerth C
    Biomed Biochim Acta; 1983; 42(11-12):S289-90. PubMed ID: 6675705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for a postsynthetic proteolytic transformation of human erythrocyte pyruvate kinase into L-type enzyme.
    Marie J; Garreau H; Kahn A
    FEBS Lett; 1977; 78(1):91-4. PubMed ID: 872942
    [No Abstract]   [Full Text] [Related]  

  • 9. Phosphorylation of human erythrocyte pyruvate kinase by soluble cyclic-AMP-dependent protein kinases. Comparison with human liver L-type enzyme.
    Marie J; Buc H; Simon MP; Kahn A
    Eur J Biochem; 1980; 108(1):251-60. PubMed ID: 6250830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The genetic system of the L-type pyruvate kinase forms in man. Subunit structure, interrelation and kinetic characteristics of the pyruvate kinase enzymes from erythrocytes and liver.
    Kahn A; Marie J; Garreau H; Sprengers ED
    Biochim Biophys Acta; 1978 Mar; 523(1):59-74. PubMed ID: 629993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteolytic modification of pig and rat liver pyruvate kinase type L including phosphorylatable site.
    Bergström G; Ekman P; Humble E; Engström L
    Biochim Biophys Acta; 1978 Feb; 532(2):259-67. PubMed ID: 623783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunological cross-reaction between eukaryote and prokaryote pyruvate kinase.
    Lincoln DR; Rittenberg MB; Black JA
    FEBS Lett; 1977 Aug; 80(1):145-7. PubMed ID: 408192
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparative study of human M2-type pyruvate kinases isolated from human leukocytes and erythrocytes of a patient with red cell pyruvate kinase hyperactivity.
    Kechemir D; Max-Audit I; Rosa R
    Enzyme; 1989; 41(3):121-30. PubMed ID: 2498076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human erythrocyte pyruvate kinase (L'/R-PK): production and characterization of a monoclonal antibody.
    Heinrichs M; Jacobasch G; Scheiner-Bobis K; Bertram S; Eigenbrodt E; Reinacher M
    Biomed Biochim Acta; 1987; 46(2-3):S223-8. PubMed ID: 3593302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pyruvate kinases from human erythrocytes and liver.
    Kahn A; Marie J
    Methods Enzymol; 1982; 90 Pt E():131-40. PubMed ID: 7154942
    [No Abstract]   [Full Text] [Related]  

  • 16. Specific spectrophotometric assay for the M isoenzymes of pyruvate kinase in plasma samples containing mixtures of the muscle (M) and liver (L) isoenzymes.
    Edwards RJ; Watts DC
    Clin Chem; 1981 Jun; 27(6):906-9. PubMed ID: 7237771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postnatal changes in canine erythrocyte pyruvate kinase isozymes.
    Mueggler PA; Carpenter S; Black JA
    Biochem Genet; 1983 Aug; 21(7-8):691-702. PubMed ID: 6626141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isozymes of pyruvate kinase in vertebrates: their physical, chemical, kinetic and immunological properties.
    Hall ER; Cottam GL
    Int J Biochem; 1978; 9(11):785-93. PubMed ID: 367845
    [No Abstract]   [Full Text] [Related]  

  • 19. Pyruvate kinase activity and response to allosteric effectors in rat erythrocytes and reticulocytes fractionated by multiple partitioning in aqueous two-phase systems.
    Pinilla M; Rodriguez-Horche P; Luque J
    Cell Biochem Funct; 1987 Oct; 5(4):301-7. PubMed ID: 3677327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electrophoretic, immunologic and kinetic characterization of erythrocyte pyruvate kinase in the Basenji dog with pyruvate kinase deficiency.
    Nakashima K; Miwa S; Shinohara K; Oda E; Tajiri M
    Tohoku J Exp Med; 1975 Oct; 117(2):179-85. PubMed ID: 1209607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.